Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Percent.
The item "Return-On-Total-Capital" stands at 0.2809 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Return On Total Capital" stands at 0.2809 Percent. This represents a decrease of -0.92 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.14 percentage points compared to the value the year prior.
The 1 year change in percentage points is -2.14.
The 3 year change in percentage points is -1.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Total Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Return On Total Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Total Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Total Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Total Capital | 280,205,508,085.11 |